Rash in psychiatric and nonpsychiatric adolescent patients receiving lamotrigine in Korea: A retrospective cohort study

Psychiatry Investigation

Volumn 9, Issue 2, 2012, Pages 174-179

  Tak, Hee Jong ^a   Ahn, Joon Ho ^a   Kim, Kun Woo ^a   Kim, Yeni ^b   Choi, Sam Wook ^c   Lee, Kyung Yeon ^a   Park, Eun Jin ^d   Bhang, Soo Young ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Seoul National University Hospital   (South Korea)

^c Eulji University   (South Korea)

^d Inje University   (South Korea)

Author keywords

Adolescent; Lamotrigine; Rash; Safety; Tolerability

Indexed keywords

ETIRACETAM; LAMOTRIGINE; LITHIUM; METHYLPHENIDATE; NEUROLEPTIC AGENT; OXCARBAZEPINE; SEROTONIN UPTAKE INHIBITOR; VALPROIC ACID;

ADOLESCENT; ADULT; ARTICLE; COHORT ANALYSIS; DIZZINESS; DRUG EFFECT; DRUG INDUCED DISEASE; DRUG INDUCED SKIN RASH; DRUG SAFETY; DRUG TOLERABILITY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; GASTROINTESTINAL SYMPTOM; HAIR LOSS; HEADACHE; HUMAN; INCIDENCE; IRRITABILITY; LOW DRUG DOSE; MAJOR CLINICAL STUDY; MALE; MOOD CHANGE; MOOD ELATION; PRURITUS; RASH; RETROSPECTIVE STUDY; SEDATION; SEIZURE; SIDE EFFECT; SOUTH KOREA; STEVENS JOHNSON SYNDROME; TREATMENT OUTCOME; TREMOR; WEIGHT GAIN; WEIGHT REDUCTION;

EID: 84863435041     PISSN: 17383684     EISSN: 19763026     Source Type: Journal    
DOI: 10.4306/pi.2012.9.2.174     Document Type: Article

References (30)

1. Glaxo Smith Kline. Prescribing Information: Lamictal.[Online]. GlaxoSmithKline; 2009.
2. Pavuluri MN, Henry DB, Moss M, Mohammed T, Carbray JA, Sweeney JA. Effectiveness of lamotrigine in maintaining symptom control in pediatric bipolar disorder. J Child Adolesc Psychopharmacol 2009;19:75-82.
3. Martin A, Volkmar FR, Lewis M. Lewis's Child and Adolescent Psychiatry: A Comprehensive Textbook. 4th Edition. Philadelphia: Lippincott Williams & Wilkins; 2007.
4. Sadock BJ, Kaplan HI, Sadock VA. Kaplan & Sadock's Synopsis of Psychiatry: Behavioral Sciences/ Clinical Psychiatry. Philadelphia: Lippincott Williams & Wilkins; 2007.
5. Guberman AH, Besag FM, Brodie MJ, Dooley JM, Duchowny MS, Pellock JM, et al. Lamotrigine-associated rash: risk/benefit considerations in adults and children. Epilepsia 1999;40:985-991.
6. Mockenhaupt M, Messenheimer J, Tennis P, Schlingmann J. Risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptics. Neurology 2005;64:1134-1138.
7. Leeder JS. Mechanisms of idiosyncratic hypersensitivity reactions to antiepileptic drugs. Epilepsia 1998;39(Suppl 7):S8-S16.
8. Roujeau JC. Immune mechanisms in drug allergy. Allergol Int 2006;55: 27-33.
9. Rapp R P, Norton JA, Young B, Tibbs PA. Cutaneous reactions in head-injured patients receiving phenytoin for seizure prophylaxis. Neurosurgery 1983;13:272-275.
10. Brodie MJ, Overstall P W, Giorgi L. Multicentre, double-blind, randomised comparison between lamotrigine and carbamazepine in elderly patients with newly diagnosed epilepsy. The UK Lamotrigine Elderly Study Group. Epilepsy Res 1999;37:81-87.
11. Chadwick D. Safety and efficacy of vigabatrin and carbamazepine in newly diagnosed epilepsy: a multicentre randomised double-blind study. Vigabatrin European Monotherapy Study Group. Lancet 1999; 354:13-19.
12. Wong IC, Mawer GE, Sander J W. Factors influencing the incidence of lamotrigine-related skin rash. Ann Pharmacother 1999;33:1037-1042.
13. Hirsch LJ, Weintraub DB, Buchsbaum R, Spencer HT, Straka T, Hager M, et al. Predictors of Lamotrigine-associated rash. Epilepsia 2006; 47:318-322.
14. Chou JC, Fazzio L. Maintenance treatment of bipolar disorder: Applying research to clinical practice. J Psychiatr Pract 2006;12:283-299.
15. Caranasos GJ, Stewart RB, Cluf LE. Drug-induced illness leading to hospitalization. JAMA 1974;228:713-717.
16. Messenheimer JA. Rash in adult and pediatric patients treated with lamotrigine. Can J Neurol Sci 1998;25:S14-S18.
17. Schatzberg AF. Employing pharmacologic treatment of bipolar disorder to greatest effect. J Clin Psychiatry 2004;65(Suppl 15):15-20.
18. Kowatch RA, DelBello MP. Pharmacotherapy of children and adolescents with bipolar disorder. Psychiatr Clin North Am 2005;28:385-397.
19. Bhangoo RK, Lowe CH, Myers FS, Treland J, Curran J, Towbin KE, et al. Medication use in children and adolescents treated in the community for bipolar disorder. J Child Adolesc Psychopharmacol 2003;13:515-522.
20. Chang K, Saxena K, Howe M. An open-label study of lamotrigine adjunct or monotherapy for the treatment of adolescents with bipolar depression. J Am Acad Child Adolesc Psychiatry 2006;45:298-304.
21. Biederman J, Joshi G, Mick E, Doyle R, Georgiopoulos A, Hammerness P, et al. A prospective open-label trial of lamotrigine monotherapy in children and adolescents with bipolar disorder. CNS Neurosci Ther 2010;16:91-102.
22. Chang JS, Joe SH, Cha BS, Moon ES, Ha TH, Yoon IY, et al. Lamotrigine augmentation in patients with treatment-resistant major depressive disorder: a naturalistic study. Korean J Psychopharmacol 2008;19:276-282.
23. Woo YS, Bahk WM, Jon DI, Joo YH, Kim W, Seo JS, et al. Rash in adult patients receiving lamotrigine to treat bipolar I disorder in Korea: a multicenter, prospective, naturalistic, open-label trial. Prog Neuropsy-chopharmacol Biol Psychiatry 2009;33:1147-1152.
24. Zeng K, Wang X, Xi Z, Yan Y. Adverse effects of carbamazepine, phenytoin, valproate and lamotrigine monotherapy in epileptic adult Chinese patients. Clin Neurol Neurosurg 2010;112:291-295.
25. Alvestad S, Lydersen S, Brodtkorb E. Rash from antiepileptic drugs: influence by gender, age, and learning disability. Epilepsia 2007;48:1360-1365.
26. Tran C, Knowles SR, Liu BA, Shear NH. Gender differences in adverse drug reactions. J Clin Pharmacol 1998;38:1003-1009.
27. Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Applications, 3rd Edition. Cambridge: Cambridge University Press; 2008.
28. Choonara I, Gill A, Nunn A. Drug toxicity and surveillance in children. Br J Clin Pharmacol 1996;42:407-410.
29. Rodnitzky RL. Drug-induced movement disorders in children and adolescents. Expert Opin Drug Saf 2005;4:91-102.
30. Aguilar EJ, Keshavan MS, Martinez-Quiles MD, Hernandez J, Gomez-Beneyto M, Schooler NR. Predictors of acute dystonia in first-episode psychotic patients. Am J Psychiatry 1994;151:1819-1821.